ACHV - CIK 0000949858
The table below shows ACHIEVE LIFE SCIENCES, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$6.93M | -$11.09M | -$5.29M | -$8.30M | -$6.78M | -$6.45M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | $14.28M | $11.35M | - | - | - | - |
| Dividends paid | - | - | - | - | - | - |
ACHIEVE LIFE SCIENCES, INC. reported operating cash flow of -$49.47M for fiscal year 2025. That is down 66.2% from -$29.77M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$202.00K (FY 2016) to -$49.47M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $21.00K | - | $56.11M | $47.00K | $95.00K | $236.00K |